Takeda Pharmaceutical will cut around 4,500 global positions. These reductions are planned for fiscal year 2026. Hundreds of Massachusetts employees are also facing layoffs. The company attributes these cuts to the decline of its dr-g VYVANSE. This restructuring aims to fund new dr-g development and launches.
Cambridge, Massachusetts
https://www.masslive.com/news/2026/05/takeda-is-laying-off-4500-by-years-end-with-hundreds-of-mass-employees-on-the-line.html